0001143313-23-000063.txt : 20230913
0001143313-23-000063.hdr.sgml : 20230913
20230913135717
ACCESSION NUMBER: 0001143313-23-000063
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20230913
DATE AS OF CHANGE: 20230913
EFFECTIVENESS DATE: 20230913
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: First Light Acquisition Group, Inc.
CENTRAL INDEX KEY: 0001855485
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 862967193
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40789
FILM NUMBER: 231252272
BUSINESS ADDRESS:
STREET 1: 11110 SUNSET HILLS ROAD #2278
CITY: RESTON
STATE: VA
ZIP: 20190
BUSINESS PHONE: 202-503-9255
MAIL ADDRESS:
STREET 1: 11110 SUNSET HILLS ROAD #2278
CITY: RESTON
STATE: VA
ZIP: 20190
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NYSE AMERICAN LLC
CENTRAL INDEX KEY: 0001143313
IRS NUMBER: 522127241
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 Wall Street
CITY: New York
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-5414
MAIL ADDRESS:
STREET 1: 11 Wall Street
CITY: New York
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE MKT LLC
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Amex
DATE OF NAME CHANGE: 20090402
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Alternext US LLC
DATE OF NAME CHANGE: 20081009
25-NSE
1
primary_doc.xml
X0203
0001143313
NYSE AMERICAN LLC
0001855485
First Light Acquisition Group, Inc.
001-40789
11110 SUNSET HILLS ROAD #2278
Reston
VA
VIRGINIA
20190
Units of First Light Acquisition Group, Inc., each consisting of one share of Class A common stock and one-half of one redeemable warrant
17 CFR 240.12d2-2(a)(3)
Victoria Paper
Manager, Market Watch and Proxy Compliance
2023-09-13
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
NYSE American LLC hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on September 25, 2023, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on September 12, 2023 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment.
As a result of the business combination between First Light Acquisition Group, Inc. and Calidi Biotherapeutics, Inc., which became effective on September 12, 2023, the Units of First Light Acquisition Group, Inc. will automatically separate into the component securities, and, as a result, will no longer trade as a separate security.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading before market open on September 13, 2023.